ClinConnect ClinConnect Logo
Search / Trial NCT02061059

Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes

Launched by MAASTRICHT UNIVERSITY · Feb 11, 2014

Trial Information

Current as of June 09, 2025

Unknown status

Keywords

ClinConnect Summary

For each patient two pairs of shoes will be produced by two shoemakers, one using plantar pressure measurements and one according current standard production procedures. The patient will wear one of these two pairs of shoes during a period of 3 months.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diabetes
  • neuropathy
  • prescription of therapeutic footwear
  • diabetic foot ulcer in the last 5 years
  • receiving regular preventive foot care
  • written informed consent
  • Exclusion Criteria:
  • peripheral arterial disease
  • not motivated to wear therapeutic footwear
  • active foot ulcer
  • recent vascular intervention
  • severe mobility impairment
  • amputation more proximal than toes, except a single ray amputation is allowed.
  • severe visual impairment
  • active cancer
  • severe cardiac/ pulmonary failure
  • severe oedema
  • chronic drug abuse
  • severe psychiatric illness
  • hospital admission at the time of inclusion
  • any condition that may interfere with follow-up visits.

About Maastricht University

Maastricht University is a leading academic institution in the Netherlands, renowned for its innovative approach to research and education in the health sciences. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to advance medical knowledge and improve patient outcomes. Maastricht University leverages its state-of-the-art facilities and expertise in various fields, including biomedical research, public health, and clinical practice, to conduct high-quality clinical studies that adhere to rigorous ethical standards. Committed to translating research findings into real-world applications, the university plays a pivotal role in addressing contemporary health challenges and enhancing healthcare delivery.

Locations

Maastricht, , Netherlands

Sittard, , Netherlands

Patients applied

0 patients applied

Trial Officials

Nicolaas C Schaper, PhD, MD

Principal Investigator

Maastricht University Medical Center

Hans H Savelberg, PhD

Study Director

Maastricht University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials